Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-10-16Clinical Trial Update: Fecal Microbiota Transplantation in Reversing Drug Resistance in Unresectable HCC (TALENP004)
This clinical trial update describes a study evaluating fecal microbiota transplantation to reverse drug resistance in unresectable hepatoce…
-
CLINICAL_TRIALS research · 2024-10-16Clinical Trial Update: TIPS Plus Cadonilimab in Advanced HCC with Tumor Thrombosis-associated Portal Hypertension:a Prospective, Single-arm, Phase II Study [Phase 2]
A Phase II, single-arm study evaluating the combination of TIPS and Cadonilimab for advanced hepatocellular carcinoma with tumor thrombosis-…
-
CLINICAL_TRIALS research · 2024-10-16Clinical Trial Update: CAR-T Cell Therapy Targeting GPC3 in Patients with Advanced GPC3-Positive Hepatocellular Carcinoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating a GPC3-targeted CAR-T cell therapy for advanced GPC3-positive hepatocellular carcinoma; the study is n…
-
CLINICAL_TRIALS research · 2024-10-16Clinical Trial Update: Therapeutic Effects of Immuno-targeted Therapy Combined With or Without RT for HCC
A clinical trial investigating immuno-targeted therapy with or without radiotherapy for hepatocellular carcinoma; recruitment has not yet be…
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Triple Therapy for Intermediate-advanced HCC With BDTT (TALENP002)
Clinical trial update for TALENP002 triple therapy for intermediate-advanced hepatocellular carcinoma with bile duct tumor thrombosis; curre…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Neoadjuvant Triple Therapy for Resectable HCC
A clinical trial update on neoadjuvant triple therapy for resectable hepatocellular carcinoma, currently recruiting.
-
CLINICAL_TRIALS research · 2024-10-10Clinical Trial Update: Durvalumab and Tremelimumab in Resectable HCC [Phase 2]
Phase 2 clinical trial evaluating durvalumab and tremelimumab in resectable hepatocellular carcinoma is currently recruiting.
-
CLINICAL_TRIALS research · 2024-10-09Clinical Trial Update: Correlation Study of Lipid Metabolites as Markers of Hepatocellular Carcinoma
A recruiting clinical trial investigating lipid metabolites as potential biomarkers for hepatocellular carcinoma.
-
CLINICAL_TRIALS research · 2024-10-09Clinical Trial Update: Clinical Study of Radiotherapy Combined With Camrelizumab and Apatinib in the Treatment of Liver Cancer Patients . [Phase 2]
A phase 2 clinical trial evaluating radiotherapy in combination with camrelizumab and apatinib for hepatocellular carcinoma; currently not y…
-
CLINICAL_TRIALS research · 2024-10-08Clinical Trial Update: HAIC in Combination with Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors for Advanced HCC
A clinical trial update describing a study of hepatic arterial infusion chemotherapy in combination with immune checkpoint inhibitors and ty…
-
CLINICAL_TRIALS research · 2024-10-08Clinical Trial Update: HAIC in Combination with PD-1 Inhibitors and Lenvatinib for Intermediate and Advanced HCC After the Failure of Systemic Therapy Recommended by BCLC
A registered clinical trial is evaluating hepatic arterial infusion chemotherapy in combination with PD-1 inhibitors and lenvatinib for inte…
-
CLINICAL_TRIALS research · 2024-10-04Clinical Trial Update: A Retrospective Cohort Study on Predicting Delayed Graft Function in Liver Transplant Patients with Hepatocellular Carcinoma: a Nomogram and Machine Learning Approaches.
A retrospective cohort study develops a nomogram and machine learning models to predict delayed graft function in liver transplant recipient…
-
CLINICAL_TRIALS research · 2024-10-02Clinical Trial Update: Early Transjugular Intrahepatic Portosystemic Shunt for Advanced Hepatocellular Carcinoma [NA]
The document reports on an ongoing study evaluating early transjugular intrahepatic portosystemic shunt (TIPS) for advanced hepatocellular c…
-
CLINICAL_TRIALS research · 2024-10-01Clinical Trial Update: Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers
Clinical trial update on detecting tumor cells and tumor DNA in blood, urine, and bone marrow of patients with solid cancers; the study is c…
-
CLINICAL_TRIALS research · 2024-09-27Clinical Trial Update: A Study of SCG101 TCR-T Cell Therpay in the Treatment of Subjects With Hepatitis B Virus-Related [Phase 1]
A Phase 1 clinical trial evaluating SCG101 TCR-T Cell Therapy for hepatitis B virus–related hepatocellular carcinoma is currently recruiting…
-
CLINICAL_TRIALS research · 2024-09-23Clinical Trial Update: Prognosis Stratification for Advanced HCC Receiving TACE with PD-1/PD-L1 Inhibitors and Molecular Target Therapies
This clinical trial update shows a recruiting study at Zhongda Hospital evaluating prognosis-based stratification for advanced hepatocellula…
-
CLINICAL_TRIALS research · 2024-09-23Clinical Trial Update: bTAE-HAIC Combined With System Therapy for Intermediate-advanced Huge HCC [NA]
A clinical trial is evaluating balloon-occluded transarterial embolization with hepatic arterial infusion chemotherapy (bTAE-HAIC) plus syst…
-
CLINICAL_TRIALS research · 2024-09-23Clinical Trial Update: Anti-cancer Potentiality of Saffron Against Hepatocellular Carcinoma [Phase 4]
A Phase 4 clinical trial from Ain Shams University is evaluating saffron extract as a potential treatment for hepatocellular carcinoma, whic…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Measuring the Density of Iodine in Lipiodol Depositions: Detecting an Invisible Residual Tumor After Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma [NA]
This clinical trial update describes a study to measure iodine density in Lipiodol deposits to detect an invisible residual tumor after conv…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: The Study of KN046 in Combination With Lenvatinib in Advanced Hepatocellular Carcinoma [Phase 2]
Phase 2 study of KN046 in combination with lenvatinib for advanced hepatocellular carcinoma has completed; results are not described in this…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: To Quantify the Impact of Addition of the GAAD Score to Imaging in Patients with Chronic Liver Disease Eligible for HCC Surveillance.
A clinical trial is evaluating whether adding the GAAD Score to imaging improves hepatocellular carcinoma surveillance in patients with chro…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Second-line Systemic Therapy Combined with SBRT for HCC with Oligoprogression After Standard First-line Systemic Treatment [Phase 2]
A Phase 2 clinical trial evaluating second-line systemic therapy in combination with SBRT for hepatocellular carcinoma with oligoprogression…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Clinical Study of VG161 in Subjects with Advanced Primary Liver Cancer [Phase 1]
A Phase 1 clinical study of VG161 for advanced primary liver cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Multi-mode Ablation and Molecular Imaging Multi-omics Study for Digestive-Origin Malignant Liver Tumors [NA]
This clinical trial from Fudan University investigates multi-mode ablation and molecular imaging with multi-omics for digestive-origin malig…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: TACE With Thermosensitive Nanogel Versus Embosphere for HCC [NA]
This clinical trial compares transarterial chemoembolization using a thermosensitive nanogel versus Embosphere embolization for unresectable…